Gut microbiota-derived metabolites: Potential targets for cardiorenal syndrome
Open Access
- 25 February 2025
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 214, 107672
Abstract
No abstract availableKeywords
This publication has 194 references indexed in Scilit:
- Gut microbiota regulates oxidative stress and inflammation: a double-edged sword in renal fibrosisCellular and Molecular Life Sciences, 2024
- TMAO Impairs Mouse Aortic Vasodilation by Inhibiting TRPV4 Channels in Endothelial CellsJournal of Cardiovascular Translational Research, 2024
- Next-generation probiotics: the upcoming biotherapeuticsMolecular Biology Reports, 2024
- Effect of 1-year lifestyle intervention with energy-reduced Mediterranean diet and physical activity promotion on the gut metabolome and microbiota: a randomized clinical trialThe American Journal of Clinical Nutrition, 2024
- Gut microbiota in heart failure and related interventionsiMeta, 2023
- Effect of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Outcomes in Patients with Diabetes: A Meta-analysis of Randomized Controlled TrialsAdvances in Nutrition, 2023
- Dietary interventions and nutritional supplements for heart failure: a systematic appraisal and evidence mapEuropean Journal of Heart Failure, 2021
- Indoxyl sulfate‐induced calcification of vascular smooth muscle cells via the PI3K/Akt/NF‐κB signaling pathwayMicroscopy Research and Technique, 2019
- Mechanisms of tissue factor induction by the uremic toxin indole-3 acetic acid through aryl hydrocarbon receptor/nuclear factor-kappa B signaling pathway in human endothelial cellsArchives of Toxicology, 2018
- Potential therapeutic interventions for chronic kidney disease‐associated sarcopenia via indoxyl sulfate‐induced mitochondrial dysfunctionJournal of Cachexia, Sarcopenia and Muscle, 2017